Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("FOUNTZILAS, G")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 130

  • Page / 6
Export

Selection :

  • and

Retinoids in the management of head and neck cancer. An updateFOUNTZILAS, G.Journal of chemotherapy. 1994, Vol 6, Num 2, pp 127-138, issn 1120-009XArticle

The role of taxanes as a component of neoadjuvant chemotherapy for breast cancerGOGAS, H; FOUNTZILAS, G.Annals of oncology. 2003, Vol 14, Num 5, pp 667-674, issn 0923-7534, 8 p.Article

Paclitaxel : Epirubicin in metastatic breast cancer : a reviewRAZIS, E. D; FOUNTZILAS, G.Annals of oncology. 2001, Vol 12, Num 5, pp 593-598, issn 0923-7534Article

Kombinierte Radiochemotherapie bei lokal fortgeschrittenem Nasopharynxkarzinom = Combined chemoradiotherapy in locally advanced nasopharyngeal carcinomaDANIILIDIS, J; CONSTANTINIDIS, J; FOUNTZILAS, G et al.HNO. Hals-, Nasen-, Ohrenärzte. 2001, Vol 49, Num 9, pp 732-738, issn 0017-6192Article

Vertical partial laryngectomy : our results after treating 81 cases of T2 and T3 laryngeal carcinomasDANIILIDIS, J; NIKOLAOU, A; FOUNTZILAS, G et al.Journal of laryngology and otology. 1992, Vol 106, Num 4, pp 349-352, issn 0022-2151Article

Sensitivity of human pancreatic carcinoma cell line (MIA PaCa-2) to bisantrene and theprubicin in vitroFOUNTZILAS, G; LIM, L. O; YUNIS, A. A et al.In vitro. 1984, Vol 20, Num 9, pp 685-691, issn 0073-5655Article

Treatment of unresectable recurrent head and neck carcinoma with 13-cis-retinoic acid and interferon-α. A phase II studyNIKOLAOU, A. C; FOUNTZILAS, G; DANIILIDIS, I et al.Journal of laryngology and otology. 1996, Vol 110, Num 9, pp 857-861, issn 0022-2151Article

Schedule-dependent interaction of cytarabine plus doxorubicin or cytarabine plus mitoxantrone in acute myelocytic leukemia cells in cultureFOUNTZILAS, G; INOUE, S; OHNUMA, T et al.Leukemia. 1990, Vol 4, Num 5, pp 321-324, issn 0887-6924Article

Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotypeRAMPIAS, T; PECTASIDES, E; RIMM, D et al.Annals of oncology. 2013, Vol 24, Num 8, pp 2124-2131, issn 0923-7534, 8 p.Article

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP casesGOLFINOPOULOS, V; PENTHEROUDAKIS, G; MALAMOU-MITSI, V et al.Annals of oncology. 2012, Vol 23, Num 10, pp 2725-2730, issn 0923-7534, 6 p.Article

Analysis of 7 Immunohistochemical Markers in Male Germ Cell Tumors Demonstrates the Prognostic Significance of p53 and MIB-1PECTASIDES, D; PAPAXOINIS, G; ZIZI, A et al.Anticancer research. 2009, Vol 29, Num 2, pp 737-744, issn 0250-7005, 8 p.Article

Contribution of BRCAI germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer casesARMAOU, S; PERTEST, M; KONSTANTOPOULOU, I et al.British journal of cancer. 2009, Vol 101, Num 1, pp 32-37, issn 0007-0920, 6 p.Article

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer : A Hellenic Cooperative Oncology Group (HeCOG) studyKOUTRAS, A. K; KALOGERAS, K. T; ZOGRAFOS, G et al.British journal of cancer. 2008, Vol 99, Num 11, pp 1775-1785, issn 0007-0920, 11 p.Article

Weekday on-weekend off oral capecitabine : a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyPENTHEROUDAKIS, G; PAPPAS, P; MARSELOS, M et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 5, pp 733-739, issn 0344-5704, 7 p.Article

A Randomized Trial to Compare the Efficacy and Safety of Antiemetic Treatment with Ondansetron and Ondansetron Zydis in Patients with Breast Cancer Treated with High-dose EpirubicinPECTASIDES, D; DAFNI, U; ARAVANTINOS, G et al.Anticancer research. 2007, Vol 27, Num 6C, pp 4411-4417, issn 0250-7005, 7 p.Article

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters : final results of a double-blind, placebo-controlled phase III trialKARTHAUS, M; KRETZSCHMAR, A; BARONIUS, W et al.Annals of oncology. 2006, Vol 17, Num 2, pp 289-296, issn 0923-7534, 8 p.Article

Mitoxantrone plus gemcitabine in pretreated patients with metastatic breast cancerONYENADUM, A; GOGAS, H; FOUNTZILAS, G et al.Journal of chemotherapy. 2006, Vol 18, Num 2, pp 192-198, issn 1120-009X, 7 p.Article

Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma : a randomized phase II study of the Hellenic Cooperative Oncology GroupBAFALOUKOS, D; TSOUTSOS, D; CHRISTODOULOU, C et al.Annals of oncology. 2005, Vol 16, Num 6, pp 950-957, issn 0923-7534, 8 p.Article

Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancerARAVANTINOS, G; BAFALOUKOS, D; FOUNTZILAS, G et al.Annals of oncology. 2003, Vol 14, Num 7, pp 1094-1099, issn 0923-7534, 6 p.Article

Temozolomide in combination with docetaxel in patients with advanced melanoma: A phase II study of the Hellenic Cooperative Oncology GroupBAFALOUKOS, D; GOGAS, H; GEORGOULIAS, V et al.Journal of clinical oncology. 2002, Vol 20, Num 2, pp 420-425, issn 0732-183XArticle

Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOPECONOMOPOULOS, T; DIMOPOULOS, M. A; FOUNTZILAS, G et al.European journal of haematology. 2002, Vol 68, Num 3, pp 135-143, issn 0902-4441Article

Tumor volumetry as predictive and prognostic factor in the management of ovarian cancerANDREOPOULOU, E; ANDREOPOULOS, D; ADAMIDIS, K et al.Anticancer research. 2002, Vol 22, Num 3, pp 1903-1908, issn 0250-7005Article

Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapyGIATROMANOLAKI, A; STATHOPOULOS, G. P; KOUKOURAKIS, M. I et al.American journal of clinical oncology. 2001, Vol 24, Num 3, pp 222-226, issn 0277-3732Article

Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapyKOUKOURAKIS, M. I; GIATROMANOLAKI, A; FOUNTZILAS, G et al.Clinical cancer research. 2000, Vol 6, Num 2, pp 381-389, issn 1078-0432Article

Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancerGIATROMANOLAKI, A; KOUKOURAKIS, M. I; GEORGOULIAS, V et al.International journal of cancer. 1999, Vol 80, Num 6, pp 810-817, issn 0020-7136Article

  • Page / 6